Delivery Order SPE2DB22D3004-SPE2DB25FPR78

Award Date 2/25/25
Potential Completion Date 2/26/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,149.24 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML medical products. The contract has an ultimate completion date of February 19, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, with ID SPE2DB24D2013|SPE2DB25FCHEX, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product, with a ceiling value of $2,909.70 and a completion date of January 15, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,296.60 firm fixed-price delivery order contract covers the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
This federal contract award, SPE2DB20D2002|SPE2DB25FL11G, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,028.01, is a Delivery Order on a Firm Fixed Price basis to provide NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,044.98 firm fixed-price delivery order is for NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product, with a performance period through January 14, 2025. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FALM2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,649.67, is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,299.07 firm fixed-price delivery order contract is for the provision of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of January 22, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,033.57 delivery order contract is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a critical pharmaceutical product. The contract has a period of performance through May 4, 2023 and is a firm fixed-price delivery order type. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, valued at $1,848.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This contract award, with ID SPE2DB24D1007 and SPE2DB25FCAFL, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,345.70 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product, to support healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPR78
    Delivery Order

This federal contract award, with ID SPE2DB22D3004|SPE2DB25FPR78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,442.39, is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product used in healthcare settings.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC, which runs through November 2026, covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract does not have a set-aside designation, indicating open competition.

Generated 5/27/25, 9:55 AM